The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer

The Emerging Role of miRNAs for the Radiation Treatment of Pancreatic Cancer

Today, pancreatic cancer is the seventh leading cause of cancer-related deaths worldwide with a five-year overall survival rate of less than 7%. Only 15–20% of patients are eligible for curative intent surgery at the time of diagnosis. Therefore, neoadjuvant treatment regimens have been introduced i...

Full description

Bibliographic Details
Main Authors: Lily Nguyen, Daniela Schilling, Sophie Dobiasch, Susanne Raulefs, Marina Santiago Franco, Dominik Buschmann, Michael W. Pfaffl, Thomas E. Schmid, Stephanie E. Combs
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
pancreatic cancer
miRNA
radiotherapy
radioresistance
personalized medicine
biomarker
Online Access:https://www.mdpi.com/2072-6694/12/12/3703

Internet

https://www.mdpi.com/2072-6694/12/12/3703

Similar Items